Open Access
E3S Web Conf.
Volume 218, 2020
2020 International Symposium on Energy, Environmental Science and Engineering (ISEESE 2020)
Article Number 03015
Number of page(s) 5
Section Environmental Chemistry and Environmental Pollution Analysis and Control
Published online 11 December 2020
  1. Flanagan M B. Primary High-Risk Human Papillomavirus Testing for Cervical Cancer Screening in the United States: Is It Time?[J]. Archives of pathology & laboratory medicine, 2018, 142(6): 688-692. [CrossRef] [PubMed] [Google Scholar]
  2. Gagliardi A, Porter V L, Zong Z, et al. Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade–specific epigenome and transcriptome landscapes[J]. Nature Genetics, 2020, 52(8):800-810. [CrossRef] [PubMed] [Google Scholar]
  3. Hee L Y, Kyung K M, Young M H, et al. Proteomic Analysis of Pelvic Autonomic Nerve in Nervesparing Radical Hysterectomy for Cervical Carcinoma.[J]. Cancer genomics & proteomics, 2018, 15(4):337-342. [CrossRef] [PubMed] [Google Scholar]
  4. Yang L, Wang Y, Shi S, et al. The TNF‐α‐induced expression of miR‐ 130b protects cervical cancer cells from the cytotoxicity of TNF‐α[J]. FEBS Open Bio, 2018, 8(4):614-627. [CrossRef] [PubMed] [Google Scholar]
  5. Guo M, Huang E, Liu X, et al. Volumetric Modulated Arc Therapy versus Fixed-Field Intensity Modulated Radiotherapy in Radical Irradiation for Cervical Cancer without Lymphadenectasis: Dosimetric and Clinical Results[J]. Oncol Res Treat, 2018, 41(3):105-109. [CrossRef] [PubMed] [Google Scholar]
  6. Gall C M L, Weiden J, Eggermont L J, et al. Dendritic cells in cancer immunotherapy[J]. Nature Materials, 2018, 17(6):2123-2130. [Google Scholar]
  7. Popovic A, Jaffee E M, Zaidi N. Emerging strategies for combination checkpoint modulators in cancer immunotherapy[J]. Journal of Clinical Investigation, 2018, 128(8):3209-3218. [CrossRef] [Google Scholar]
  8. Ribas A, Wolchok J D. Cancer immunotherapy using checkpoint blockade[J]. ence, 2018, 359 (6382): 1350-1355. [CrossRef] [Google Scholar]
  9. Dahlén, Eva, Veitonm?Ki N, Norlén Per. Bispecific antibodies in cancer immunotherapy[J]. Therapeutic Advances in Vaccines & Immunotherapy, 2018, 6(1):3-17. [CrossRef] [Google Scholar]
  10. June C H, O’Connor R S, Kawalekar O U, et al. CAR T cell immunotherapy for human cancer[J]. ence, 2018, 359 (6382):1361-1365. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.